SPDR S&P Biotech ETF (XBI) has run up sharply this week and our XBI Jul Week Two (7/8) 75 Call is deep in the money.
I am recommending we allow our shares to be called away. I will recommend a put soon to reduce our net debit on the position.
Current Stock Price: $84.47
Cost Basis: $89.77
Action: Allow shares to be called away
Net Debit: $14.77